* CareMax Inc CMAX.OQ CMAX.O is expected to show a rise
in
quarterly revenue when it reports results on August 9.
* The Miami Florida-based company is expected to report a
203.2% increase in revenue to $136.208 million from $44.92
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for CareMax Inc is for
a loss
of 5 cents per share. For the same quarter last year, the
company reported a loss of 26 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareMax Inc
is
$12, above its last closing price of $7.10.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 -0.02 -0.02 -0.19 Missed -660
Dec. 31 2022 -0.06 -0.06 -0.04 Beat 33.3
Sep. 30 2021 -0.08 -0.08 -0.03 Beat 63.6
Jun. 30 2021 -0.04 -0.04 -0.26 Missed -550
This summary was machine generated August 5 at 18:34 GMT. All
figures in US dollars unless otherwise stated